TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.

Naval Daver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.